Search

everythinglearnresearchcommunity

for

Search:↓

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Ritlecitinib was generally well tolerated in children with alopecia areata.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Pulsatilla chinensis compounds may help prevent stress-related hair loss.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Clascoterone may be a promising treatment for hair loss.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

A new compound effectively inhibits human 5α-reductase 1.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

FLRG and follistatin have different roles in wound healing.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Clascoterone 1% cream is a promising new treatment for acne.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.